MSD enters licensing pact with five Indian generic firms to manufacture, distribute COVID-19 antiviral drug molnupiravir

MSD enters licensing pact with five Indian generic firms to manufacture, distribute COVID-19 antiviral drug molnupiravir Under the agreements, MSD will provide licences to these manufacturers to supply molnupiravir to India and more than 100 LMICs. MSD is also in discussions with the Medicines Patent Pool to explore the potential for additional licences.

from Moneycontrol Business News https://ift.tt/2S1U12h
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...